Cutera, Inc.

    Cutera, Inc.

    NNASDAQ:CUTR
    0.01
    USD
    +0.00
    (-2.35%)
    Cutera, Inc.
    NASDAQ:CUTR
    (Nasdaq Stock Market)

    Recent

    price

    0.01

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2008
    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    TTM
    USD
    6.53
    4.04
    3.93
    4.37
    5.48
    5.17
    5.48
    6.79
    8.93
    10.92
    11.82
    12.89
    8.85
    12.93
    13.46
    10.68
    7.74
    Revenue per Share
    -0.22
    -1.33
    -0.78
    -0.73
    -0.46
    -0.33
    -0.74
    -0.32
    0.19
    2.16
    -2.23
    -0.88
    -1.43
    0.12
    -4.39
    -8.19
    -7.17
    Basic EPS, GAAP
    0.28
    -0.01
    -0.62
    -0.43
    -0.2
    0.2
    -0.35
    -0.15
    0.11
    0.97
    -0.09
    -0.23
    -1.09
    0.01
    -4.78
    -8.59
    -6
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    2.46
    1.3
    0.5
    -0.24
    -0.7
    -1.01
    -1.77
    -2.12
    -2.04
    0.21
    -1.74
    -2.58
    -3.61
    -3.25
    -7.49
    -15.25
    -19.44
    Book Value per Share
    8.7
    7.53
    7
    6.6
    6.17
    5.61
    5.51
    3.48
    4.51
    4.58
    3.27
    3.16
    3.33
    3.09
    -0.88
    -8.71
    -12.68
    Tangible Book Value per Share
    13
    13
    14
    14
    14
    14
    14
    14
    13
    14
    14
    14
    17
    18
    19
    20
    20
    Basic Weighted Avg Shares
    83
    54
    53
    60
    77
    75
    78
    95
    118
    151
    163
    182
    148
    231
    252
    212
    155
    Sales/Revenue/Turnover
    -3.78
    -17.68
    -20.83
    -17.3
    -8.83
    -7.05
    -13.59
    -4.77
    2.03
    4.67
    -8.23
    -6.64
    -15.46
    0.79
    -15.13
    -73.57
    -93.22
    Operating Margin (%)
    1
    1
    1
    1
    2
    1
    1
    1
    1
    1
    1
    2
    1
    1
    3
    9
    9
    Depreciation Expense
    -3
    -18
    -11
    -10
    -7
    -5
    -11
    -4
    3
    30
    -31
    -12
    -24
    2
    -82
    -163
    -144
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    5.26
    - -
    - -
    - -
    - -
    39.08
    - -
    - -
    - -
    Effective Tax Rate (%)
    -3.44
    -32.93
    -19.74
    -16.69
    -8.47
    -6.36
    -13.58
    -4.69
    2.18
    19.8
    -18.91
    -6.8
    -16.17
    0.89
    -32.62
    -76.67
    -92.59
    Profit Margin (%)
    102
    96
    90
    89
    89
    85
    82
    49
    59
    45
    40
    36
    52
    176
    345
    181
    105
    Working Capital
    - -
    - -
    - -
    - -
    1
    1
    1
    1
    1
    - -
    - -
    5
    20
    148
    428
    428
    429
    LT Debt
    112
    101
    95
    92
    91
    84
    81
    50
    61
    65
    46
    46
    57
    57
    -15
    -172
    -253
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    3.9
    - -
    - -
    - -
    - -
    0.74
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -9.28
    - -
    - -
    - -
    - -
    12.57
    - -
    - -
    - -
    Return on Capital (%)
    -8.73
    -72.62
    -87.59
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    USD

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    ST Debt
    3
    3
    3
    LT Borrowings
    419
    420
    420
    LT Finance Leases
    10
    9
    8
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    20
    20
    20
    Market Capitalization
    29
    30
    16

    Working Capital

    USD

    •

    in mil. unless spec.
    Mar'24
    Jun'24
    Sep'24
    Total Current Assets
    235
    211
    161
    Cash, Cash Equivalents & STI
    105
    83
    58
    Accounts Receivable, Net
    37
    35
    33
    Inventories
    73
    80
    57
    Total Current Liabilities
    73
    60
    56
    Payables & Accruals
    58
    48
    44
    ST Debt
    3
    3
    3
    Deferred Revenue
    9
    9
    8

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    88.48%
    185.47%
    1,031.88%
    Free Cash Flow
    -4,003.02%
    -8,048.13%
    90.52%
    Net Income, GAAP
    -330.2%
    -814.12%
    97.76%
    Sales/Revenue/Turnover
    12.91%
    8.56%
    -15.86%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    58
    64
    63
    67
    252
    2023
    55
    62
    46
    50
    212
    2024
    39
    34
    33
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.84
    -2.53
    -0.62
    -0.4
    -4.39
    2023
    -1.42
    -1.68
    -2.22
    -2.87
    -8.19
    2024
    -1.14
    -1.23
    -1.94
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business

    Company News

    • Cutera® and Restimulate Health™ Announce Strategic Partnership to Advance Rehabilitation with truFlex Technology

    • Cutera® Appoints Chris House as Chief Technology Officer and Charles Hunt as Vice President of Design & Experience, Reinforcing Commitment to Innovation

    • Cutera® Successfully Completes Restructuring Transaction and Moves Forward with Enhanced Capital Structure

    • Cutera Announces Voluntarily Delisting from Nasdaq

    • Cutera Takes Steps to Strengthen Financial Foundation and Position the Company for Long-Term Success

    • Dermatology Devices Market Report 2025, with Key Player Profiles for Cutera, Lumenis, Alma Lasers, Solta Medical and Aesthetic Group

    • Aesthetic Medicine Market Expected To Reach USD 170.41 Billion by 2032, Growing at CAGR 8.40% | Allergan, Alma Lasers, Cutera, Cynosure

    • Cutera® Announces Partnership with the Adaptive Training Foundation

    • Cutera, Inc. (CUTR) Q3 2024 Earnings Call Transcript

    • Cutera (CUTR) Reports Q3 Loss, Misses Revenue Estimates

    • Cutera® to Announce Third Quarter Results on November 7, 2024

    • Cutera (CUTR) Stock Drops 5.14% Amid Financial Challenges

    • Cutera, Inc (CUTR) Q2 2024 Earnings Call Transcript

    • Cutera (CUTR) Reports Q2 Loss, Misses Revenue Estimates

    • Investor Alert: 3 Ugly Celebrity Beauty Brand Stocks Not Worth Your Dollar

    • Cutera® Announces New Survey Data During Acne Awareness Month

    • Cutera® Appoints Jeryl L. Hilleman to Board of Directors

    • The 3 Most Undervalued Meme Stocks to Buy in June 2024

    • Cutera® Announces AviClear® Investor Webinar

    • If You Can Only Buy One Meme Stock Now, It Better Be One of These 3 Names